Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cod, unspecified is an allergenic extract derived from cod fish (typically Gadus species) used as a diagnostic tool to identify IgE-mediated hypersensitivity in patients suspected of having a cod fish allergy. The extract contains a complex mixture of proteins, most notably the calcium-binding muscle protein parvalbumin (Gad c 1), which is the primary allergen. When applied during skin prick testing or administered intradermally, the proteins in the extract cross-link allergen-specific IgE antibodies bound to the surface of mast cells and basophils. This interaction triggers the degranulation of these cells and the subsequent release of inflammatory mediators like histamine, resulting in a visible wheal-and-flare reaction that confirms sensitization.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cod allergenic extract.